Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308997 · ClinicalTrials.gov registry record · Phase 2
Transcranial Magnetic Stimulation for "Voices"
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 85
- Enrollment target
NCT00308997 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 85 participants.
The verdict
NCT00308997, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 85 participants
- Enrollment target
Study Summary
This study will determine the efficacy of MRI-guided transcranial magnetic stimulation (TMS)in reducing "voices" and other symptoms experienced by people with schizophrenia and schizoaffective disorder. In addition, the study will determine duration of improvement obtained during the course of trial participation via on-going monthly contact with study participants for up to 1 year after the trial.
Interventions
- DEVICE 1-hertz Repetitive Transcranial Magnetic Stimulation
- DEVICE Active 1-Hertz Repetitive transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2006-02 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308997
The ClinicalTrials.gov registry entry for NCT00308997 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 1-hertz Repetitive Transcranial Magnetic Stimulation is the first listed.
NCT00308997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308997 about?
NCT00308997 is a clinical study titled "Transcranial Magnetic Stimulation for "Voices"". This study will determine the efficacy of MRI-guided transcranial magnetic stimulation (TMS)in reducing "voices" and other symptoms experienced by people with schizophrenia and schizoaffective disorder. In addition, the study will determine duration of improvement obtained during the course of trial...
What is the current status of trial NCT00308997?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 85 participants. The study started on 2006-02. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00308997?
The interventions under investigation include: 1-hertz Repetitive Transcranial Magnetic Stimulation (DEVICE), Active 1-Hertz Repetitive transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT00308997?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.